Abstract
A retroviral construct encoding polyoma middle-sized T antigen was used to generate transformed endothelial cell lines from heart (H5V), brain (B9V), and whole-embryo (E10V) of C57BL/6 mice. When injected into syngeneic recipients, H5V and the less studied B9V and E10V cells caused vascular tumors which, depending on the number of cells inoculated, regressed or progressed, leading to death of the host. When H5V cells were injected into immunodeficient mice, tumors were observed with inocula which did not form lesions in immunocompetent recipients and regression did not occur. Treatment with anti-LFA-1, anti-Thy-1.2, and anti-CD8 antibodies abolished rejection; anti-CD4 was a somewhat less effective inhibitor of resistance. Animals with progressive tumors exhibited secondary lesions in various organs with prominent skin involvement in nude mice. Histologically, the tumors had the appearance of a hemangioma, with areas resembling Kaposi sarcoma. Cells lining vascular lacunae had the morphological features of injected H5V cells. The lesions were characterized by prominent neovascularization and mononuclear cell infiltration. Southern blot hybridization analysis revealed that approximately 5% of the cells in the tumor mass were transplanted H5V cells. Thus, the H5V transformed endothelial line causes vascular lesions that are sustained to a large extent by recruitment of host cells and manifests full malignant behavior only in immunocompromised hosts. The hypothesis of a tumor sustained by a minute proportion of transformed cells, which recruit host elements and express full malignant behavior only in immunodeficient hosts, would account for several features of some vascular neoplasms in man.
MeSH Terms
Animals
Antigens, Polyomavirus Transforming/physiology
Cell Division
Cell Line, Transformed
Cell Transformation, Neoplastic
Cell Transformation, Viral
Cloning, Molecular
Endothelium, Vascular/pathology
Immunocompromised Host
Mice
Mice, Inbred C57BL
Neoplasms, Vascular Tissue/etiology,immunology,pathology
Chemicals
Antigens, Polyomavirus Transforming
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Garlanda C
Istituto Mario Negri, Milan, Italy.
Parravicini C
Sironi M
De Rossi M
Wainstok de Calmanovici R
Carozzi F
Bussolino F
Colotta F
Mantovani A
Vecchi A
References (21)
21 references, click to expand
-
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
J Exp Med. 1986 Oct 1;164(4):1179-92
PMID: 2944983
-
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.
N Engl J Med. 1992 May 28;326(22):1456-63
PMID: 1489383
-
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.
Cell. 1988 Jan 15;52(1):121-31
PMID: 3345558
-
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
Science. 1988 Oct 21;242(4877):426-30
PMID: 3262925
-
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.
Science. 1988 Oct 21;242(4877):430-3
PMID: 2459779
-
Cytokine regulation of endothelial cell function.
FASEB J. 1992 May;6(8):2591-9
PMID: 1592209
-
Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene.
Cancer Res. 1993 Aug 15;53(16):3812-6
PMID: 8393382
-
Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.
Eur J Cell Biol. 1994 Apr;63(2):247-54
PMID: 8082649
-
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.
Science. 1989 Jan 13;243(4888):223-6
PMID: 2643161
-
Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
Blood. 1989 Apr;73(5):1113-5
PMID: 2930836
-
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.
Cell. 1989 Jun 16;57(6):1053-63
PMID: 2736622
-
A review of Kaposi's sarcoma.
Adv Cancer Res. 1989;53:73-87
PMID: 2477996
-
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
Nature. 1990 May 3;345(6270):84-6
PMID: 2184372
-
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4068-72
PMID: 1693429
-
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.
Cell. 1990 Aug 10;62(3):435-45
PMID: 2379237
-
The conundrum of Kaposi's sarcoma.
Eur J Cancer. 1990;26(6):657-9
PMID: 2144149
-
Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas.
Exp Cell Res. 1991 Oct;196(2):302-13
PMID: 1893941
-
Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines.
J Immunol. 1991 Oct 1;147(7):2122-9
PMID: 1918946
-
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.
Science. 1992 Mar 13;255(5050):1430-2
PMID: 1542792
-
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
Science. 1992 Mar 13;255(5050):1432-4
PMID: 1542793
-
Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene.
Cell. 1987 Nov 20;51(4):529-37
PMID: 2445489